Altre lingue Hisamitsu Pharmaceutical Co., Inc.

Azioni

4530

JP3784600003

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 02/05/2024			Variaz. 5gg	Var. 1 gen.
3.740 ^JPY	-2,07%		-1,03%	-13,25%

11/04	L'utile attribuibile di Hisamitsu Pharmaceutical è aumentato del 19% nell'anno fiscale 2024	MT
11/01	Hisamitsu Pharmaceutical Co., Inc. fornisce una guida agli utili consolidati per l'anno fiscale che terminerà il 29 febbraio 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Hisamitsu Pharmaceutical : Notice of Convocation of the 122nd Annual General Meeting of Shareholders	25/04
Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024	11/04
Hisamitsu Pharmaceutical : Earning Document	11/04
Hisamitsu Pharmaceutical : Notification of Completion of Construction of the New Research Laboratory “SAGA Global Research Center”	13/03
Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise	12/01
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024	11/01
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Second Quarter and Provides Dividend Guidance for the Full Year Ending February 29, 2024	11/01
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	26/12
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on July 13, 2023, has closed with 2,000,000 shares, representing 2.58% for ¥9,792.58 million.	25/12
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	05/12
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares	05/12
Hisamitsu Pharmaceutical : Announcement regarding completion of partial transfer of assets, related to S-Cup and Lacalut from SSP Co., Ltd.	31/10/23
Hisamitsu Pharmaceutical’s Attributable Profit up 29.4% in Fiscal Q2 on Improved Net Sales	09/10/23
Hisamitsu Pharmaceutical : Earning Document	06/10/23
Hisamitsu Pharmaceutical : Earning Document	06/10/23
Hisamitsu Pharmaceutical Co., Inc. Reports Earnings Results for the Half Year Ended August 31, 2023	06/10/23
Hisamitsu Pharmaceutical : Notification regarding Skin Care Cosmetics with Microneedle Technology	20/09/23
Hisamitsu Pharmaceutical : Notification of the commencement of the Phase II clinical study of HP-6050 in Japan (a transdermal formulation for sedation)	19/09/23
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	04/09/23
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares	04/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Hisamitsu Pharmaceutical Co., Inc.

Azioni

4530

JP3784600003

Altre lingue

Filtri